Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
This clinical trial update presents results from a follow-up study of patients treated with imlifidase prior to kidney transplantation, eval…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Cyclosporine a Pretreatment and Kidney Graft Function [Phase 4]
Phase 4 clinical trial update evaluating pretreatment with Cyclosporine A and its impact on kidney graft function in brain-death-related kid…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Kidney Transplant Low-AGE Diet Study [NA]
A completed clinical trial assessing the impact of a low-AGE diet in kidney transplant recipients; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Sex Impact on Long-term Outcomes of LDKT
Clinical trial update exploring how biological sex affects long-term outcomes after living-donor kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Kidney Transplant Recipients -ChronoVAX [NA]
This completed trial investigated whether the timing of influenza vaccination affects the immune response in kidney transplant recipients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore [NA]
A completed clinical trial evaluated whether achieving early target trough levels of tacrolimus using CYP3A5-guided dosing provides advantag…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients [Phase 4]
A Phase 4 trial assessing the efficacy and safety of switching from cyclosporin to tacrolimus in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts [Phase 3]
This Phase 3 trial compares standard-dose versus low-dose Advagraf (tacrolimus extended-release) with or without ACE inhibitors/ARBs to eval…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients [Phase 4]
This Phase 4 study evaluates switching stable kidney transplant recipients from cyclosporine to Advagraf (tacrolimus extended-release) and c…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
Clinical trial update describing kidney transplantation patients converted from twice-daily tacrolimus (Prograf) to once-daily tacrolimus (A…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection [Phase 4]
A Phase 4 clinical trial in kidney transplant patients completed, investigating optimal immune suppression to prevent kidney rejection.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation [Phase 4]
A completed Phase 4 clinical trial studied the pharmacokinetics of Modigraf (Tacrolimus Granules) in children following solid organ transpla…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients [Phase 4]
A pediatric open-label Phase 4 follow-up trial of Modigraf (tacrolimus) in de novo transplant recipients evaluating safety and efficacy; the…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial update assessing delayed or standard tacrolimus (Prograf) with induction therapy followed by conversion to extended-r…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation [Phase 4]
A Phase 4 Asian study completed evaluating the safety and efficacy of optimized dosing of Advagraf (Tacrolimus) for kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Five-year follow-up data from patients previously enrolled in an Advagraf tacrolimus trial after liver or kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. [Phase 4]
Phase 4 clinical trial evaluating kidney function in kidney transplant recipients on anti-rejection therapy including tacrolimus, with or wi…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Comparison of Analgesic Efficacy ESP Block and QLB II in Kidney Transplantation [Phase 4]
A Phase 4 trial comparing ESP block and quadratus lumborum block II for intraoperative and postoperative analgesia in kidney transplant pati…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients
This completed observational study evaluated the safety and efficacy of ATG-F in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Better Evidence for Selecting Transplant Fluids [Phase 3]
Phase 3 clinical trial update evaluating different fluids used during kidney transplantation to reduce complications, with the study status …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function
A completed clinical trial examining whether donor CIRBP levels correlate with transplanted kidney function.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Treg Modulation With CD28 and IL-6 Receptor Antagonists [Phase 1, Phase 2]
Phase 1/2 clinical trials evaluating regulatory T cell modulation using CD28 and IL-6 receptor antagonists in kidney transplant recipients h…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Treg Therapy in Subclinical Inflammation in Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating regulatory T cell therapy for subclinical inflammation in adult living donor kidney transplant recipients; the st…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial [NA]
The TAKE IT Trial, evaluating IT-based methods to improve regimen adherence in kidney transplant recipients, has completed with results post…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) [Phase 3]
A Phase 3 study comparing rATG alone versus rATG with IVIG for induction immunosuppression in HLA-incompatible kidney transplantation has co…